GBC Bioscience Speaker Series: Peter Greenleaf, President, MedImmune LLC
MedImmune: Its Future in Maryland's Bioscience Industry
Join us to hear from Jeff Greenleaf, the new CEO of MedImmune, one of the world's leading biotechnology companies. Hear how MedImmune leveraged its own growth and where the new CEO sees the company positioning itself for the future growth of the state's bioscience industry.
GBC members/biotech companies: $25